BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6416770)

  • 1. Problems of working with different parasitic strains.
    Ciba Found Symp; 1983; 99():252-5. PubMed ID: 6416770
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trypanosoma cruzi and Chagas disease: a proposal for a analysis of the genomic configuration in host-parasite interactions].
    Brandão A
    Rev Soc Bras Med Trop; 2006; 39 Suppl 3():112. PubMed ID: 17605218
    [No Abstract]   [Full Text] [Related]  

  • 3. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.
    Yoshida N
    Parasitol Int; 2008 Jun; 57(2):105-9. PubMed ID: 18234547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Trypanosoma cruzi-host-cell interplay: location, invasion, retention.
    Andrade LO; Andrews NW
    Nat Rev Microbiol; 2005 Oct; 3(10):819-23. PubMed ID: 16175174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indeterminate Chagas' disease: Trypanosoma cruzi strain and re-infection are factors involved in the progression of cardiopathy.
    Bustamante JM; Rivarola HW; Fernández AR; Enders JE; Fretes R; Palma JA; Paglini-Oliva PA
    Clin Sci (Lond); 2003 Apr; 104(4):415-20. PubMed ID: 12653687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C; Cortez M; Ferreira D; Yoshida N
    Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental infection of the monkey Cebus apella sp. by Trypanosoma cruzi. II. Re-isolation of strains and study of their characteristics in albino mice].
    Rassy MR; Kloetzel J; Nogaroto SL; Carvalhal SS; de Almeida EA; Chaia G
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):275-82. PubMed ID: 6424218
    [No Abstract]   [Full Text] [Related]  

  • 9. Chagas disease parasite induces behavioural changes in the kissing bug Mepraia spinolai.
    Botto-Mahan C; Cattan PE; Medel R
    Acta Trop; 2006 Jul; 98(3):219-23. PubMed ID: 16780784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fighting the oxidative assault: the Trypanosoma cruzi journey to infection.
    Piacenza L; Alvarez MN; Peluffo G; Radi R
    Curr Opin Microbiol; 2009 Aug; 12(4):415-21. PubMed ID: 19616990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural heterogeneity of Trypanosoma cruzi: biological and medical implications.
    Dvorak JA
    J Cell Biochem; 1984; 24(4):357-71. PubMed ID: 6432804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An agent-based model for predicting the prevalence of Trypanosoma cruzi I and II in their host and vector populations.
    Devillers H; Lobry JR; Menu F
    J Theor Biol; 2008 Dec; 255(3):307-15. PubMed ID: 18805428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: intracellular host-parasite relationship in murine infection.
    Grimaud JA; Andrade SA
    Cell Mol Biol; 1984; 30(1):59-65. PubMed ID: 6421485
    [No Abstract]   [Full Text] [Related]  

  • 14. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.
    Zhang L; Tarleton RL
    J Infect Dis; 1999 Aug; 180(2):480-6. PubMed ID: 10395865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of the Cebus apella monkey to different strains of T. cruzi after single or repeated inoculations.
    Falasca A; Grana D; Buccolo J; Gili M; Merlo A; Zoppi J; Mareso E
    Bull Pan Am Health Organ; 1986; 20(2):117-37. PubMed ID: 3094612
    [No Abstract]   [Full Text] [Related]  

  • 16. Sabotage and exploitation in macrophages parasitized by intracellular protozoans.
    Denkers EY; Butcher BA
    Trends Parasitol; 2005 Jan; 21(1):35-41. PubMed ID: 15639739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi surface mucins: host-dependent coat diversity.
    Buscaglia CA; Campo VA; Frasch AC; Di Noia JM
    Nat Rev Microbiol; 2006 Mar; 4(3):229-36. PubMed ID: 16489349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological properties of Trypanosoma cruzi metacyclic trypomastigotes: usefulness for studying Chagas' disease (brief report).
    Contreras VT; Araque WH; Delgado VS
    Biol Res; 1993; 26(1-2):315-6. PubMed ID: 7670544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi: infectivity modulation of a clone after passages through different hosts.
    Pérez Brandán C; Padilla AM; Diosque P; Basombrío MA
    Exp Parasitol; 2006 Oct; 114(2):89-93. PubMed ID: 16564526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy.
    Araújo-Jorge TC; Waghabi MC; Soeiro Mde N; Keramidas M; Bailly S; Feige JJ
    Cytokine Growth Factor Rev; 2008; 19(5-6):405-13. PubMed ID: 18938102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.